Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization - Sevcik, MA; Ghilardi, JR; Peters, CM; Lindsay, TH; Halvorson, KG; Jonas, BM; Kubota, K; Kuskowski, MA; Boustany, L; Shelton, DL; Mantyh, PW (Pain, 2005)
15836976